eVitalRx
PrivateLast Round
Seed
May 1, 2023
Total Funding Raised
$2.5M
Company Overview
eVitalRx is a healthtech company that provides a cloud-based pharmacy management ERP platform for retail and chain pharmacies to manage inventory, billing, and customer relationships.
Sector
Healthcare & Life Sciences
Verticals
Enterprise Resource Planning, Pharma Supply Chain, Retail Technology, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Payment Processing Fee, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eVitalRx Comparables
Compare eVitalRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medbikri | 86% | |
| Instinct Innovations Private Limited | 85% | |
| Localwell | 85% |
eVitalRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 1, 2023 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors increased 45% MoM to 163.1K.
- Feb 5, 2025
Grew 17% QoQ, from 112 to 131 employees.
eVitalRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about eVitalRx's valuation, stock price, and market status.
Is eVitalRx a public or private company?
eVitalRx is a private company.
What is the current stock price of eVitalRx?
eVitalRx is a private company with no public stock price. No recent secondary market data is available.
How much is eVitalRx worth (valuation)?
Valuation information for eVitalRx is not publicly available.
Can I buy eVitalRx stock?
eVitalRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was eVitalRx's last funding round?
eVitalRx's most recent funding round was Seed on May 1, 2023.
Who are the main investors in eVitalRx?
Investor information for eVitalRx is not publicly disclosed.
Will eVitalRx IPO soon?
No public IPO plans have been announced for eVitalRx.
How can I track eVitalRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eVitalRx's secondary market activity and sign up for updates.